Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Sponsor

Beacon Therapeutics (USA) Inc.

United States 14193 Northwest 119th Terrace Suite 10, 32615-9410, United States

About the sponsor

Beacon Therapeutics (USA) Inc. is focused on inherited retinal disorders, with research activity centered on X-linked retinitis pigmentosa linked to RPGR mutations. The sponsor’s clinical work is directed toward conditions that affect the structure and function of the retina.

  • X-linked retinitis pigmentosa
  • RPGR-associated retinal disease
  • Retinal degeneration

The therapeutic emphasis is on preserving visual function in a progressive retinal dystrophy population.

About Specializations

Beacon Therapeutics (USA) Inc. runs clinical trials in conditions such as Retinitis pigmentosa, among others.

All trials

Ongoing trials

Clinical trials registered by this sponsor – none is enrolling right now.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

1 clinical trial

Retinitis pigmentosa

Not yet recruiting
Registered drugNo placebo
Countries:SpainSpain
  • Participants:0–17 years · 18–64 years
  • Substances:Acetazolamide
  • Sponsor:Beacon Therapeutics (USA) Inc.

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.